Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized salbutamol or isotonic saline after a 1500 m race in elite skaters with exercise-induced bronchoconstriction
NL-OMON37214Active, not recruiting
- Sponsor
- Tjongerschans
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of salbutamol in exercise-induced bronchospasm (EIB) (3 arms), sponsored by Tjongerschans. Started Dec 2012; status: active, not recruiting.
02
Drugs
salbutamol
03
Conditions
exercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on NL-OMON37214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37214.